Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move-
(CSE: $CURA.C) (OTCQX: $CURLF), (CSE: $CXXI.C) (CSE: $SPR.C) (OTC: $SRUTF)
News from
Province Brands, HelloMD, Panaxia Pharmaceutical
Industries Israel
Delta, Kelowna, BC –May 1,
2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/05011CURA-CURLF-CXXI-SPR-SRUTF.asp
Today’s podcast overview/transcript:
Good
morning and welcome to another episode of Investorideas.com “potcasts”, looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
In
today’s podcast I focus on a few early announcements from some interesting
companies.
But
first, HelloMD will now provide patients in Canada with convenient access
to practitioner-led advice about medical cannabis through a new relationship
with Shoppers Drug Mart's online
medical cannabis platform.
Since
its launch in 2015, HelloMD's turnkey telehealth platform has facilitated more
than 100,000 virtual consults between medical cannabis patients and licensed
practitioners. HelloMD is currently active in Canada and the United States.
The
Medical Cannabis by Shoppers website now features
a
dedicated portal operated
by HelloMD. Patients can access
live
video consultations with
licensed healthcare practitioners through the dedicated portal seven days a
week, from the comfort of their home.
Following
a consultation with a healthcare practitioner, patients that receive a medical
document authorizing their registration as a medical cannabis patient may
return to the Medical Cannabis by Shoppers website to register and begin
choosing from its wide selection of approved products, or direct HelloMD to
send their medical document to an alternative licensed producer.
Panaxia
Pharmaceutical Industries Israel
and the pharmaceutical company Rafa,
announced the signing of a collaboration agreement
with PlantEXT Ltd., an Israeli-Canadian medical cannabis company. According to
the agreement, the parties will co-develop the next generation of medical
cannabis products intended for patients suffering from Inflammatory Bowel
Disease, and who are authorized to receive treatment with medical cannabis. The
treatment consists of medical cannabis suppositories, which contain a
proprietary composition based on a combination of defined and precise active
ingredients from the cannabis plant. The novelty lies in the fact that for the
first time, a medical cannabis product will be developed in order to offer a
targeted solution to patients suffering from Crohn's disease and Colitis, in
order to decrease the level of inflammation in the intestine.
Inflammatory
bowel disease (Crohn's or Ulcerative Colitis) are chronic diseases that can
appear at any age. Now for the first time, treatment with medical cannabis for
these patients will be delivered utilizing an accepted, conventional
pharmaceutical delivery system, and which is based on clinical research. This
will offer a potential solution and increase accessibility of the treatment to
a greater number of patients who need it and are eligible to receive it.
The
active ingredients in the rectal cannabis suppositories are absorbed at a
relatively fast rate through the many blood vessels and are not first
metabolized by the liver, unlike medications that are taken orally. As a
result, the biological availability of the active ingredients rises on the one
hand, and a speedy physical response occurs on the other hand.
According
to Dr. Dadi Segal, Panaxia CEO, "Panaxia has already gained proven and
successful experience with cannabis suppositories in the American market. The
agreement that was signed today is an additional milestone in revolutionizing
accessibility of medical cannabis also in Israel, which we are leading together
with Rafa. By enabling cannabis accessibility via traditional pharmaceutical
delivery systems, and which are not based on smoking, we are striving to enable
patients who are eligible for medical cannabis treatment, for a wide range of
diseases, to be able to benefit from its unique attributes, subject at all
times to the advice of a qualified medical specialist."
Curaleaf Holdings,
Inc. (CSE: CURA) (OTCQX: CURLF), a leading vertically integrated cannabis
operator in the United States, today announced it has signed a definitive agreement to
acquire the state-regulated cannabis business of Cura Partners, Inc., owners of
the Select brand, in an all-stock transaction valued at C$1.27 billion or
US$948.8 million.
The
acquisition includes Select's manufacturing, processing, distribution,
marketing and retailing operations and all adult-use cannabis products marketed
under the Select brand name, including all intellectual property. Based in
Portland, Oregon, Select is the most well-known cannabis wholesale brand in the
country. With its THC products sold in more than 900 retailers, it is the
leading cannabis brand in key Western states, including California, Arizona,
Oregon and Nevada.
The
highly complementary acquisition brings together two of the strongest cannabis
brands, Curaleaf and Select, to offer a full-range of products across the U.S.
The combination will provide immediate geographic diversification with
Curaleaf's footprint on the East Coast and Select's brand strength on the West
Coast.
The
proposed transaction combines Curaleaf's retail locations, vertical
integration, wellness brand and strong East Coast market presence with Select's
wholesale model, lifestyle brand and leading West Coast market presence.
Significant cost synergies are expected to be realized through operational
efficiencies, greater economies of scale, supply chain efficiencies and
increased vertical integration.
C21 Investments, Inc. (CSE:
CXXI) today
announced the launch of a new product: the Phantom
Vape Pen. The highly anticipated vape pen solves a number of industry
challenges by providing uniform viscosity, shelf stability, oil clarity as well
as consistency of flavour and potency.
"Vaping is the main driver of
concentrate sales, which are projected to reach $8.4 billion in USA sales by
2022," said Sky Pinnick, Chief Marketing Officer, C21 Investments. "Our strategy for the Phantom Vape Pen
was to provide an affordable, superior product at a highly competitive price
point helping to bridge the gap for flower traditionalists to high quality
concentrates."
The Phantom Vape Pen is made by Phantom
Farms, a Clean Green Certified cannabis cultivator in Oregon. Using the
industry leading CCELL technology with Phantom Farms proprietary terpene-heavy
CO2 + distillate extract formulation, the Phantom Vape Pen provides native
flavour (terpene) retention, and consistent potency and vaporization
experience.
Sproutly Canada, Inc. (CSE:
SPR) (OTC:
SRUTF), and OCC Holdings Ltd., an affiliate of
Moosehead Breweries Limited, announced that
they have entered into a definitive agreement to form an exclusive joint
venture to develop, produce, and market non‐alcoholic cannabis-infused beverages in Canada using
Sproutly’s proprietary, naturally produced water soluble cannabinoids known as
‘Infuz2O’. Both companies will bring their respective strengths to
the joint venture to develop a line of great tasting cannabis beverages
featuring a rapid onset and offset effect unique to the category. Sproutly also
hosted a conference call with Keith Dolo, CEO, Sproutly Canada and Matthew Oland,
Moosehead executive and incoming CEO of the JV, at 9:30am Eastern Time this
morning on May 1, 2019.
Dooma
Wenshuh, CEO and Co-Founder of Province Brands commented on this announcement, saying “We are delighted to see the
excitement and build-up to the next phase of cannabis legalization in Canada
later this year. With today’s news of
Sproutly & Moosehead coming after recent match-ups from AB InBev &
Tilray, Constellation Brands & Canopy Growth, Heineken & CannaCraft,
and Molson-Coors & Hexo there can be little doubt that beverages will be
the dominant form of cannabis consumption in the years ahead.”
“Above these headlines, Province Brands
of Canada continues to stand out as the only beverage maker that will deliver
beer brewed entirely from the cannabis plant, not an infused concoction, thus
providing consumers with the experience of authenticity, high-quality, and
choice that they demand.”
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available
on iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via
Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use
of cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
